Drugs Will Kill'Ya - Just Ask Mrs. Lawson Mr. Parker ventures into Mrs. Lawson's Bio-Medical class as they prepare a toxicology report on a hypothetical drug overdose. By: Cindy Huskey … Continue reading →

NOVA scienceNOW:55 - Can My Car Live Forever,Replacing BodyParts,Can We Slow Aging,Human Hibernation Can We Live Forever? This NOVA scienceNOW poses the question - Can We Live Forever? - and host Neil deGrasse Tyson tackles one of science's major challenges in each episode. He will guide us as he explores dramatic discoveries and the frontiers of research that connect each central, provocative mystery. This provocative episode of NOVA scienceNOW examines whether we can slow down the aging process, looks at the latest on human hibernation, and checks in with bioengineers and a computer scientist inventing ways to keep us "going forever." Neil deGrasse Tyson also takes a lighthearted look at whether the tricks that have kept a 1966 Volvo running for 2.7 million miles can also help the human body go the extra mile. Can My Car Live Forever - 01:55 Irv Gordon, a retired science teacher from East Patchogue, New York, has managed to keep his 1966 Volvo P1800 going for four decades and over 2.7 million miles. How has he managed it, and can this recipe for longevity help the human body go the extra mile? Neil deGrasse Tyson visits Irv and takes a spin in his … Continue reading →

Grandpa 5000 Tries Drugs it hurt him bag By: xXshadowtailzXx … Continue reading →

Quartz Coaching with Sean Sean came to Quartz Life struggling to find a way to get to live his passion of working with kids and showing them an alternative lifestyle without the need for booze or drugs. It was brilliant to watch the transformation in Sean from week 1 to week 5, and now he is on his way to living his dream and he has a new approach to life, and the impact the coaching has had is not only affecting him but his family and friends too. Inspirational journey Sean. By: QuartzLifeTV … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/mwvzrl/global_ophthalmic) has announced the addition of the "Global Ophthalmic Drugs Market 2011-2015" report to their offering. TechNavio's analysts forecast the Global Ophthalmic Drugs market to grow at a CAGR of 9.98 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in prevalence of eye disorders. The Global Ophthalmic Drugs market has also been witnessing the trend of increased focus on combination therapies. However, the low patient compliance could pose a challenge to the growth of this market. This report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Ophthalmic Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this market space are Alcon Inc., Allergan, Inc., Merck and Co., Inc., Novartis AG, and Pfizer Inc. Key questions answered in this report: - What will the market size be in 2015 and what will the growth rate be? - What are the key market trends? - … Continue reading →

By Val Willingham, CNN updated 5:39 AM EST, Fri January 11, 2013 People taking insomnia drugs such as Ambien should consult their doctors before changing the dosage, the FDA says. STORY HIGHLIGHTS (CNN) -- The Food and Drug Administration announced Thursday it is requiring manufacturers of insomnia products, such as Ambien, Edluar and Zolpimist, to lower their current recommended doses. The drugs contain an active ingredient called zolpidem, which causes drowsiness. Researchers have found high levels of zolpidem in the blood of some patients the morning after a dose -- so much so it affects patients' cognitive skills, including their ability to drive. The FDA said using lower doses of zolpidem will cut down on the amount of the drug found in the bloodstream the following morning. It also noted that the recommended dosage should be lower for women, because they don't process zolpidem out of their system as quickly as men. The agency recommended the dosage of zolpidem for women be lowered to 5 milligrams from 10 milligrams for immediate-release products and to 6.25 milligrams from 12.5 milligrams for extended-release products. Patients who use the extended-release forms of these drugs have an even higher risk for next morning impairment, … Continue reading →